These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 10695487)

  • 21. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging.
    Corti R; Fuster V; Fayad ZA; Worthley SG; Helft G; Chaplin WF; Muntwyler J; Viles-Gonzalez JF; Weinberger J; Smith DA; Mizsei G; Badimon JJ
    J Am Coll Cardiol; 2005 Jul; 46(1):106-12. PubMed ID: 15992643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pathophysiology of plaque disruption and thrombosis in acute ischemic syndromes.
    Moreno PR
    J Stroke Cerebrovasc Dis; 2001; 10(2 Pt 2):2-9. PubMed ID: 17903843
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spontaneous plaque rupture and secondary thrombosis in apolipoprotein E-deficient and LDL receptor-deficient mice.
    Calara F; Silvestre M; Casanada F; Yuan N; Napoli C; Palinski W
    J Pathol; 2001 Sep; 195(2):257-63. PubMed ID: 11592107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [New insights towards catheter-based identification of vulnerable plaque].
    Rodríguez-Granillo GA; Regar E; Schaar JA; Serruys PW
    Rev Esp Cardiol; 2005 Oct; 58(10):1197-206. PubMed ID: 16238988
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fibrinogen and atherothrombosis: vulnerable plaque or vulnerable patient?].
    Jaeger BR; Labarrere CA
    Herz; 2003 Sep; 28(6):530-8. PubMed ID: 14569394
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dietary lipid lowering modifies plaque phenotype in rabbit atheroma after angioplasty: a potential role of tissue factor.
    Jeanpierre E; Le Tourneau T; Six I; Zawadzki C; Van Belle E; Ezekowitz MD; Bordet R; Susen S; Jude B; Corseaux D
    Circulation; 2003 Oct; 108(14):1740-5. PubMed ID: 14504177
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravascular modalities for detection of vulnerable plaque: current status.
    MacNeill BD; Lowe HC; Takano M; Fuster V; Jang IK
    Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):1333-42. PubMed ID: 12805071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [From the single vulnerable plaque, to the multiple complex coronary plaques. From their basis, to the modern therapeutic approach. A clinical reality in the spectrum of the acute coronary syndromes].
    Lupi Herrera E; Chuquiure Valenzuela E; Gaspar J; Férez Santander SM
    Arch Cardiol Mex; 2006; 76 Suppl 1():S6-34. PubMed ID: 16830832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regression of atherosclerotic renal artery stenosis with aggressive lipid lowering therapy.
    Khong TK; Missouris CG; Belli AM; MacGregor GA
    J Hum Hypertens; 2001 Jun; 15(6):431-3. PubMed ID: 11439320
    [No Abstract]   [Full Text] [Related]  

  • 30. Vessel wall apoptosis and atherosclerotic plaque instability.
    Kavurma MM; Bhindi R; Lowe HC; Chesterman C; Khachigian LM
    J Thromb Haemost; 2005 Mar; 3(3):465-72. PubMed ID: 15748235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The vulnerable plaque: a necessary concept in the management of atherothrombosis].
    Rioufol G; Finet G
    Arch Mal Coeur Vaiss; 2002 Dec; 95(12):1210-4. PubMed ID: 12611042
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition on serum matrix metalloproteinase-13 and tissue inhibitor matrix metalloproteinase-1 levels as a sign of plaque stabilization.
    Cevik C; Otahbachi M; Nugent K; Warangkana C; Meyerrose G
    J Cardiovasc Med (Hagerstown); 2008 Dec; 9(12):1274-8. PubMed ID: 19001938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [From the single vulnerable plaque, to the multiple complex coronary plaques. From their basis, to the modern therapeutic approach. A clinical reality in the spectrum of the acute coronary syndromes].
    Lupi Herrera E; Chuquiure Valenzuela E; Gaspar Hernández J; Férez Santander SM
    Arch Cardiol Mex; 2006; 76 Suppl 2():S239-40. PubMed ID: 17017109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concepts in acute coronary syndromes.
    Foo RS; De Bono DP
    Singapore Med J; 2000 Dec; 41(12):606-10. PubMed ID: 11296789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stabilization of atherosclerotic plaques: new mechanisms and clinical targets.
    Libby P; Aikawa M
    Nat Med; 2002 Nov; 8(11):1257-62. PubMed ID: 12411953
    [No Abstract]   [Full Text] [Related]  

  • 36. Testing the hypothesis of atherosclerotic plaque lipid depletion during lipid therapy by magnetic resonance imaging: study design of Carotid Plaque Composition Study.
    Zhao XQ; Phan BA; Chu B; Bray F; Moore AB; Polissar NL; Dodge JT; Lee CD; Hatsukami TS; Yuan C
    Am Heart J; 2007 Aug; 154(2):239-46. PubMed ID: 17643572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unstable coronary plaques and cardiac events in myocardial infarction-prone Watanabe heritable hyperlipidemic rabbits: questions and quandaries.
    Shiomi M; Fan J
    Curr Opin Lipidol; 2008 Dec; 19(6):631-6. PubMed ID: 18957890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Plaque disruption and thrombosis: potential role of inflammation and infection.
    Shah PK
    Cardiol Rev; 2000; 8(1):31-9. PubMed ID: 11174871
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Physiopathology of myocardial infarction: the acute coronary occlusion].
    Allal J; Coisne D; Christiaens L; Pornin M
    Arch Mal Coeur Vaiss; 1998 Apr; 91 Spec No 2():9-17. PubMed ID: 9749271
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What have we learned about the biology of atherosclerosis? The role of inflammation.
    Libby P
    Am J Cardiol; 2001 Oct; 88(7B):3J-6J. PubMed ID: 11595192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.